Association between Statins and Retinal Vascular Occlusion
A Population-Based Cohort Study
Bibliographic Data
| ID | 15499064 |
|---|---|
| Authors | Chien-Cheng Chien (Tri-Service General Hospital), Po‐Huang Chen (0000-0002-0280-6417, Tri-Service General Hospital), Chi‐Hsiang Chung (0000-0002-4576-9900, Tri-Service General Hospital), Chien‐An Sun (0000-0001-9041-0537, Fu Jen Catholic University), Wu‐Chien Chien (0000-0002-3286-0780, Tri-Service General Hospital, corresponding author), Ke‐Hung Chien (Tri-Service General Hospital, corresponding author), Ke-Hung Chien (Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei City 114202, Taiwan) |
| Year | 2021 |
| Volume | 18 |
| Issue | 18 |
| Pages | 9864-9864 |
| Publication date | 2021-09-18 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Environmental Research and Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1661-7827 • E-ISSN: 1660-4601 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/ijerph18189864 |
| PMID | 34574786 |
| OpenAlex | W3200281801 |
| Language | EN |
| References cited | 46 |
Retinal vascular occlusion (RVO), including retinal arterial occlusion and retinal vein occlusion, is a common retinal vascular disease that causes visual disturbance. The exact pathogenesis of RVO remains unclear. In all types of RVO patients, hyperlipidemia is more than twofold more common than in controls. Statins have been used to control blood cholesterol levels and have been found to reduce the risk of cardiovascular morbidity and mortality. Moreover, the immunomodulatory functions of statins may play a role in treating inflammatory diseases. This study aimed to evaluate whether patients taking statins have a lower risk of developing RVO compared to patients not taking statins. Adult patients with statins usage on the index date identified from the Taiwan National Health Insurance Research Database (NHIRD) between 2000 and 2013 were included. A threefold matched group was selected using age, sex, and year of index date for comparison. During the mean follow-up period of 12.87 ± 1.88 years, the cumulative incidence of RVO was significantly lower in the statin-user group (29.96 per 105 person-years [PYs]) than in the non-statin-user group (39.35 per 105 PYs). The results showed a lower cumulative incidence rate of RVO in patients prescribed statins than in those not prescribed statins (log-rank test, p = 0.020). The adjusting hazard ratio (HR) was significantly greater for RVO in the statin-user group (adjusted HR, 0.704; 95% CI, 0.591-0.873). Statin users had a decreased risk for all types of RVO development, including central retinal artery occlusion, arterial branch occlusion, central retinal vein occlusion, and branch retinal vein occlusion. In conclusion, patients undergoing statin treatment have a lower risk of developing RVO compared to patients not taking statins
Cardiology · Cohort · Confidence interval · Cumulative incidence · Hazard ratio · Incidence (geometry · Occlusion · Statin · Medicine · Ocular Diseases and Behçet’s Syndrome · Retinal and Optic Conditions · Retinal Diseases and Treatments · Internal Medicine
| Citation velocity | historical |
|---|---|
| Highly cited | No |